Trimethoprim, a sulphonamide potentiator.
作者信息
Bushby S R, Hitchings G H
出版信息
Br J Pharmacol Chemother. 1968 May;33(1):72-90. doi: 10.1111/j.1476-5381.1968.tb00475.x.
Abstract
摘要
相似文献
1
Trimethoprim, a sulphonamide potentiator.甲氧苄啶，一种磺胺增效剂。
Br J Pharmacol Chemother. 1968 May;33(1):72-90. doi: 10.1111/j.1476-5381.1968.tb00475.x.
2
The in vivo effect of folinic acid (citrovorum factor) on the potentiation of the antibacterial activity of sulfisoxazole by trimethoprim.
J Clin Pharmacol J New Drugs. 1970 Jul-Aug;10(4):231-4.
3
Practical aspects of testing sensitivity to trimethoprim and sulphonamide.检测对甲氧苄啶和磺胺类药物敏感性的实际操作
Postgrad Med J. 1969 Nov;45:Suppl:21-9.
4
Dihydrofolate reductase inhibitors as antimicrobial agents and their potentiation by sulfonamides.
CRC Crit Rev Clin Lab Sci. 1970 Dec;1(4):565-83. doi: 10.3109/10408367009043919.
5
Biochemical background of trimethoprim-sulphamethoxazole.甲氧苄啶-磺胺甲恶唑的生化背景。
Med J Aust. 1973 Jun 30;1(2):Suppl:5-9. doi: 10.5694/j.1326-5377.1973.tb111178.x.
6
[Experimental data on the antibacterial effect of the combination sulfadoxine-trimethoprim].
Berl Munch Tierarztl Wochenschr. 1971 Mar 1;84(5):87-91.
7
[Antibacterial activity of the combination trimethoprim-sulfamethoxazole compared with antibiotics].
Schweiz Med Wochenschr. 1969 Oct 18;99(42):1505-10.
8
Plasmodium knowlesi: in vitro evaluation of antimalarial activity of folic acid inhibitors.
Exp Parasitol. 1971 Aug;30(1):88-93. doi: 10.1016/0014-4894(71)90074-9.
9
In vitro antibacterial activity of trimethoprim alone and combined with sulfonamides.
Antimicrob Agents Chemother (Bethesda). 1966;6:424-9.
10
[Trimethoprim. Folic acid antagonist--synergistic effect with sulphonamides].
Nord Med. 1970 Aug 20;84(34):1070-3.
引用本文的文献
1
Synergistic Antibacterial Interaction of Geraniol and Biogenic Silver Nanoparticles on Methicillin-Resistant .香叶醇与生物源银纳米颗粒对耐甲氧西林菌的协同抗菌相互作用
Plants (Basel). 2025 Mar 29;14(7):1059. doi: 10.3390/plants14071059.
2
Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy.甲氧苄啶/磺胺甲恶唑的群体药代动力学：肾功能不全患者或接受持续肾脏替代治疗患者的剂量优化
Clin Pharmacol Ther. 2025 Jan;117(1):184-192. doi: 10.1002/cpt.3421. Epub 2024 Aug 15.
3
Integrating bacterial molecular genetics with chemical biology for renewed antibacterial drug discovery.将细菌分子遗传学与化学生物学相结合，重新发现抗菌药物。
Biochem J. 2024 Jul 3;481(13):839-864. doi: 10.1042/BCJ20220062.
4
The impact of the human gut microbiome on the treatment of autoimmune disease.人类肠道微生物组对自身免疫性疾病治疗的影响。
Immunol Rev. 2024 Aug;325(1):107-130. doi: 10.1111/imr.13358. Epub 2024 Jun 12.
5
Lipid Nanocarriers-Enabled Delivery of Antibiotics and Antimicrobial Adjuvants to Overcome Bacterial Biofilms.脂质纳米载体介导抗生素和抗菌佐剂递送以克服细菌生物膜
Pharmaceutics. 2024 Mar 14;16(3):396. doi: 10.3390/pharmaceutics16030396.
6
Antiplasmodial Activity of β-Ionone and the Effect of the Compound on Amelioration of Anaemia and Oxidative Organ Damage in Mice Infected with Plasmodium berghei.β-紫罗兰酮的抗疟原虫活性及对感染伯氏疟原虫小鼠贫血和氧化器官损伤的改善作用。
Acta Parasitol. 2024 Mar;69(1):242-250. doi: 10.1007/s11686-023-00741-7. Epub 2023 Nov 20.
7
Enterococci Isolated from One-Day-Old Chickens and Their Phenotypic Susceptibility to Antimicrobials in the Czech Republic.从捷克共和国一日龄雏鸡中分离出的肠球菌及其对抗菌药物的表型敏感性
Antibiotics (Basel). 2023 Sep 27;12(10):1487. doi: 10.3390/antibiotics12101487.
8
Antimicrobial Drug-Drug Interactions in the Treatment of Infectious Keratitis.治疗感染性角膜炎的抗菌药物药物相互作用。
Cornea. 2023 Dec 1;42(12):1555-1561. doi: 10.1097/ICO.0000000000003304. Epub 2023 Apr 27.
9
Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance.抗生素佐剂：对抗抗生素耐药性的通用方法。
ACS Omega. 2023 Mar 14;8(12):10757-10783. doi: 10.1021/acsomega.3c00312. eCollection 2023 Mar 28.
10
The Potential of Antibiotics and Nanomaterial Combinations as Therapeutic Strategies in the Management of Multidrug-Resistant Infections: A Review.抗生素与纳米材料联合应用于多重耐药感染治疗策略的潜力：综述。
Int J Mol Sci. 2022 Nov 30;23(23):15038. doi: 10.3390/ijms232315038.
本文引用的文献
1
Successful Treatment of a Case of Proteus Septicaemia.变形杆菌败血症一例的成功治疗
Br Med J. 1962 Oct 27;2(5312):1101-2. doi: 10.1136/bmj.2.5312.1101.
2
Studies on analogs of purines and pyrimidines.嘌呤和嘧啶类似物的研究。
Ann N Y Acad Sci. 1950 Jul 7;52(8):1318-35. doi: 10.1111/j.1749-6632.1950.tb54032.x.
3
A new medium for bacteriologic diagnosis of tuberculosis.
Am J Clin Pathol. 1950 Jul;20(7):682-5. doi: 10.1093/ajcp/20.7_ts.682.
4
The mode of action of sulphonamides, proguanil and pyrimethamine on Plasmodium gallinaceum.磺胺类药物、氯胍和乙胺嘧啶对鸡疟原虫的作用方式。
Br J Pharmacol Chemother. 1955 Jun;10(2):208-14. doi: 10.1111/j.1476-5381.1955.tb00084.x.
5
[TRIAL TREATMENT OF VARIOUS "PROTEUS" INFECTIONS WITH 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL) PYRIMIDINE, OR (TRIM'ETHOPRIME)].
Presse Med (1893). 1965 Mar 27;73:893-4.
6
SUCCESSFUL TREATMENT OF PROTEUS SEPTICAEMIA WITH A NEW DRUG TRIMETHOPRIM.
Med J Aust. 1964 Jul 18;2:93-6.
7
5-BENZYL-2,4-DIAMINOPYRIMIDINES AS ANTIBACTERIAL AGENTS. I. SYNTHESIS AND ANTIBACTERIAL ACTIVITY IN VITRO.5-苄基-2,4-二氨基嘧啶类抗菌剂。I. 体外合成与抗菌活性
J Med Pharm Chem. 1962 Nov;5:1103-23. doi: 10.1021/jm01241a004.
8
9
Comparative effects of various antimetabolites on growth and synthesis of citrovorum factor by Streptococcus faecalis.多种抗代谢物对粪链球菌生长及甲酰四氢叶酸合成的比较作用
J Bacteriol. 1960 Feb;79(2):306-7. doi: 10.1128/jb.79.2.306-307.1960.
10
The relation between the binding of sulfonamides to albumin and their antibacterial efficacy.磺胺类药物与白蛋白的结合与其抗菌效力之间的关系。
J Pharmacol Exp Ther. 1960 Jul;129:282-90.
Zotero 插件